A novel signature based on microvascular invasion predicts the recurrence of HCC
In hepatocellular carcinoma (HCC) patients, microvascular invasion (MVI) is associated with worse outcomes regardless of treatment. No single reliable preoperative factor exists to predict MVI. The aim of the ...
Source: Journal of Translational Medicine - Category: Research Authors: Binbin Du, Fang Wang, Beers Jarad, Zhihui Wang and Yanzhou Zhang Tags: Research Source Type: research